Tango Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.111; its P/E ratio is -8.12; Tango Therapeutics is scheduled to report earnings on March 25, 2024, and the estimated EPS forecast is $-0.27. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	$ 10.73M	$ 9.60M	$ 5.77M	$ 6.41M	$ 6.92M
Gross Profit	$ 10.73M	$ 14.60M	$ 5.77M	$ 6.41M	-
EBIT	$ -24.11M	$ -22.10M	$ -27.57M	$ -29.60M	$ -29.92M
EBITDA	$ -21.86M	$ -22.36M	$ -26.09M	$ -28.12M	$ -29.51M
Net Income Common Stockholders	$ -21.43M	$ -20.71M	$ -26.50M	$ -27.91M	$ -29.05M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 359.88M	$ 311.51M	$ 333.64M	$ 366.70M	$ 393.29M
Total Assets	$ 428.19M	$ 379.33M	$ 403.77M	$ 436.47M	$ 464.16M
Total Debt	$ 39.51M	$ 39.89M	$ 41.37M	$ 41.13M	$ 40.73M
Net Debt	$ -320.37M	$ -271.62M	$ -292.27M	$ -325.57M	$ -352.56M
Total Liabilities	$ 151.59M	$ 166.38M	$ 176.51M	$ 186.99M	$ 191.08M
Stockholders Equity	$ 276.60M	$ 212.94M	$ 227.26M	$ 249.48M	$ 273.07M
Cash Flow	-
Free Cash Flow	$ -31.15M	$ -25.14M	$ -35.51M	$ -29.31M	$ -22.89M
Operating Cash Flow	$ -31.14M	$ -24.48M	$ -34.89M	$ -28.27M	$ -19.61M
Investing Cash Flow	$ -56.66M	$ 32.69M	$ 31.55M	$ -12.61M	$ 15.23M
Financing Cash Flow	$ 80.28M	$ 586.00K	$ 73.00K	$ 527.00K	$ 113.00K

Currency in USD

Tango Therapeutics Earnings and Revenue History

Income Statement >

Tango Therapeutics Debt to Assets

Balance Sheet >

Tango Therapeutics Cash Flow

Cash Flow >

Tango Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing